Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | geminin | 0.019 | 0.0173 | 1 |
Schistosoma mansoni | hypothetical protein | 0.019 | 0.0173 | 1 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.6977 | 1 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.01 | 0.0043 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0906 | 0.121 | 0.5 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.6977 | 1 | 1 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.6977 | 1 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0906 | 0.121 | 0.5 |
Leishmania major | DNA polymerase eta, putative | 0.01 | 0.0043 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.0043 | 0.5 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.007 | 0 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.6977 | 1 | 1 |
Mycobacterium leprae | PROBABLE NICOTINATE-NUCLEOTIDE ADENYLYLTRANSFERASE NADD (DEAMIDO-NAD(+) PYROPHOSPHORYLASE) (DEAMIDO-NAD(+) DIPHOSPHORYLASE) (NIC | 0.0319 | 0.036 | 0.5 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.01 | 0.0043 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0906 | 0.121 | 0.5 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.01 | 0.0043 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0906 | 0.121 | 0.5 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.6977 | 1 | 1 |
Echinococcus granulosus | geminin | 0.019 | 0.0173 | 1 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.6977 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.019 | 0.0173 | 1 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.6977 | 1 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0906 | 0.121 | 0.5 |
Treponema pallidum | hypothetical protein | 0.0319 | 0.036 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 11 % | Inhibition of human recombinant PDE7A1 assessed as inhibition of hydrolysis of [3H]cAMP at 10 uM after 20 mins by scintillation proximity assay | ChEMBL. | 25264825 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.